Piramal Pharma Q2 Results: Firm swings to profit as revenue jumps 28%, led by CDMO growth
Piramal Pharma swung to a net profit of ₹5.58 crore in Q2 FY27 from a loss of ₹99.2 crore a year earlier, as revenue grew 28% to ₹2,617 crore and EBITDA margin expanded to 13.3%. The company upgraded its FY27 revenue growth outlook to 19%–20%, supported by first-half business momentum and improved profitability.
Piramal Pharma swung to a net profit of ₹5.58 crore in Q2 FY27 from a loss of ₹99.2 crore a year earlier, as revenue grew 28% to ₹2,617 crore and EBITDA margin expanded to 13.3%. The company upgraded its FY27 revenue growth outlook to 19%–20%, supported by first-half business momentum and improved profitability.
What's Your Reaction?
FEDA-HQ
The Federation of Economic Development Association of India (F.E.D.A) holds the distinction of being India's most venerable umbrella organization. F.E.D.A focused on promoting economic growth in India. Economic development professionals throughout the state, along with individuals and companies in related economic development fields, work together with the F.E.D.A Members and Board of Federation to help positively influence country legislation and industrial growth. With cutting edge policy research and advisory to National and State governments on trade issues. F.E.D.A is one of the leading non-profit organizations with established credentials for enhancing economic development.
